Home / Compare / Selenium Alternatives

Buyer's guide · 2026

Playwright alternatives — for teams done writing tests as code.

We build one of the tools on this page, so verify everything here. And we'll start with the concession: Playwright is the best open framework in the category. If you're evaluating it against Cypress or Selenium, pick Playwright and stop reading. The alternatives worth your time are not alternatives to the tool. They're alternatives to the model — who writes the test, what a test is, and who keeps it running.

First, what Playwright already fixed

The framework is not your problem.

Most "Playwright alternatives" searches are looking for a better framework. There isn't one, and it's worth being precise about why.

Playwright's auto-waiting removes the largest single cause of flaky UI tests — asynchronous timing, which the largest empirical study of UI flakiness found at the root of 45% of cases (Romano et al., ICSE 2021). Its trace viewer is the best debugging artifact in the category. Execution is fast, the API is clean, and it's free. Teams that moved from Selenium to Playwright generally got what they were promised.

What they did not get is different economics. A Playwright test is still code. It still binds to a locator, and locators are still where over 70% of test breakages originate (Hammoudi, Rothermel & Tonella, ICST 2016) — Playwright's locator strategy is better than Selenium's, and the best strategy measured still fails 39% of the time after a page change (Nass et al., ACM TOSEM 2023). It is still written and maintained by engineers. The suite is faster and more reliable. The bill for keeping it is the same shape.

So if your problem was Selenium, Playwright solved it. If your problem is the cost of the people maintaining the suite, you have the best framework and the same problem.

The CTO question

What is the automation team for?

This is the decision the framework comparison was hiding.

Automation engineers exist because tests could not be executed by the people who understood the business. Someone who knew claims wrote the test; someone who knew Playwright made it run. The role is a translation layer, and it was the right layer for as long as translation was required.

When an existing manual test case can run as written, the translation step is gone. That does not make the engineers unnecessary — it makes their current work unnecessary. The suite still has to exist; it no longer needs them to exist. The headcount question changes from how many do we need to what should they be building — usually the coverage that never got written because they were repairing what had.

The exception, stated plainly. Our three-year model shows per-run execution costing more than an in-house team once a very large suite runs several times a day. At 5,000 test cases twice daily, a $1M in-house team wins by roughly $650K a year. That is a computed boundary, not an observed one, and you can reproduce it in the calculator with your own inputs. Below it — which is most teams — the same calculator will tell you what the translation layer costs.

The options

Alternatives to the model.

Four categories that change who owns the suite. The framework alternatives — Cypress, WebdriverIO — are omitted deliberately; if you want a different framework, you already have the best one.

Low-code recorders with healing

mabl, Tricentis Testim — record a flow, let AI repair selectors as the UI shifts. Strong CI/CD integration and enterprise support. Best when: you want less code without changing your QA operating model. Trade-off: recording binds you to the UI as it was, healing works on selectors rather than intent, and the suite is generally not portable.

Command-grammar NL platforms

Testsigma, Katalon, testRigor, ACCELQ — write tests in a supported natural-language vocabulary. A genuine bridge for manual testers into automation. Best when: non-technical authoring is the priority. Trade-off: existing tests must be converted into the vendor's syntax — ask to see the command reference before you commit.

Managed testing services

QA Wolf, Rainforest — someone else builds and maintains the suite, often with coverage guarantees. Several of these write Playwright under the hood, so you keep the framework and outsource the people. Best when: you have no QA capacity and don't want to build it. Trade-off: cost scales with coverage, and the capability sits outside your team.

Executors that run tests as written

Spec2RunAI, the test executor inside Spec2TestAI — our category, so weigh accordingly. Existing manual test cases run unchanged: no required keywords, no reformatting, business jargon and multi-action lines handled as written. Proven steps replay deterministically from selector memory. Best when: you already have manual test cases and the conversion project is the barrier. Trade-off: execution is priced per run, so very high-frequency suites need volume pricing — see the exception above.

The signals

When a Playwright suite has stopped paying for itself.

Not "we want fewer engineers." These are the conditions under which the suite is consuming what it was built to free.

You can't state the repair ratio. Hours spent making existing tests pass, divided by total automation hours, for the last release. If nobody knows the number, the suite is being kept on faith. Under 20%, keep it. Over 40%, it is a failing suite by any published benchmark.

The un-automated backlog never shrinks. If the people who can write a test are the same people repairing the last one, coverage is capped at engineering capacity and will stay there.

Domain experts can't contribute. The person who understands the business process cannot write the test for it. Every test is a translation, and detail is lost in each one.

The manual regression cycle still runs. If conversion never finished, you are funding a Playwright team and a manual cycle and getting the benefit of one.

Where we fit

One situation, specifically.

If your team has manual test cases — in Jira, Zephyr, qTest, Excel, Word — and a Playwright suite that covers some of them, the un-covered majority is where we fit. Those tests run as written, no rewrite into Playwright required, and the engineers who would have written them are free to build what the suite still lacks. If your suite is fully engineering-owned, well under the repair threshold, and everyone is happy, keep Playwright. We'd say that on the call.

Common questions

Quick answers.

What are the best alternatives to Playwright?

If you mean a better framework: there isn't a meaningfully better one, and Cypress or WebdriverIO would be a lateral move. If you mean a different model — changing who writes and maintains tests — four categories: low-code recorders (mabl, Testim), command-grammar platforms (Testsigma, Katalon, testRigor, ACCELQ), managed services (QA Wolf, Rainforest), and executors that run existing manual tests as written (Spec2RunAI).

Should we move off Playwright?

Not because of Playwright. The case for change is about the cost of the people maintaining the suite, and it only holds if you can measure that cost. Compute your repair ratio for the last release. Under 20%, stay. Over 40%, the suite is consuming what it was meant to free, and the three-year model will show what that costs against alternatives.

Isn't an AI executor slower and less predictable than Playwright?

On first run, an AI executor reasons through each step and is slower than a script. After that, proven steps replay deterministically from selector memory without a model call — interpretation where it's needed, determinism where it's earned. Every decision the executor makes is recorded, which is the answer to the predictability question: not "trust it," but "read what it did."

Can we keep our Playwright tests?

Yes. Nothing here requires retiring a working suite. The point is the tests you haven't written — the manual cases that never got converted because engineers were maintaining the ones that had. Those run as written alongside whatever Playwright already covers.

When does an in-house Playwright team beat per-run execution?

When a very large suite runs several times a day. Our published model puts the crossover around 5,000 test cases at twice-daily cadence, where a $1M in-house team costs less than per-run pricing. That is a computed boundary from our own calculator, and we would rather show it than have you find it.

Test the claim

Don't take our word for any of this.

Send us ten of your existing manual test cases — unedited, unformatted — and watch them run against your application.